Drawing for RHENIUM SCT

USPTO serial 90759395

RHENIUM SCT

Reviewed by CopyMark Law Group

Reg. 7787538Status 700Registered
Filing date
Status date
Registration date
May 6, 2025
Examiner
LEE, OLIVIA SUNMIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RHENIUM SCT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kari Moyer-Henry

Kari Moyer-Henry LEWIS KOHN & WALKER LLP17085 VIA DEL CAMPOSAN DIEGO, CA 92127United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer, namely, radio therapeutic preparations and radio diagnostic preparations used in the application of radioisotopes and radiation for medical purposes in the nature of nuclear medical diagnostics and therapy, oncologic diagnostics and therapy, hematologic diagnostics and therapy, radiologic diagnostics and therapy, diagnostics and therapy of pain, diagnostics and therapy of inflammations, diagnostics and therapy of metabolic disorders, palliative therapy, ablative therapy, positrons emission tomography, emission tomography with single photons, x-ray diagnostics, gamma spectrometry, nuclear spin tomography, scintigraphy, and dosimetryACTIVEDec 1, 2024
010Medical instruments and apparatus for dosimetry purposes in the field of radiotherapy, namely, apparatus for radiation therapy with radio therapeutic substance compounds; containers specially designed for holding radiopharmaceuticals sold as an integral component of apparatus for radiation therapy with radio therapeutic substance compounds; radiation dosimeters for assessing therapeutic doses of radiation delivered to patients; medical devices and instruments for introducing pharmaceutical preparations and diagnostic preparations into the human body, namely, radioactive isotope generators being medical radiation apparatus and microfluidics instruments being radioisotope therapy apparatus for therapy with radio therapeutic substance compounds; medical apparatus and instruments for diagnostic radiopharmaceutical use for the application of pharmaceutical preparations and diagnostic preparations, namely, apparatus for radiation therapy with radio therapeutic substance compounds; radioisotope therapy apparatus and instruments for the application of pharmaceutical preparations and diagnostic preparations, namely, apparatus for radiation therapy with radio therapeutic substance compounds; control, regulation and measuring apparatuses, namely, scintillation counters sold as an integral component of medical radiation apparatus, medical dose meter that measures the total radiation dose received by a patient during a diagnostic procedure, and radiation dosimeters for assessing therapeutic doses of radiation delivered to patients, all the foregoing comprising parts of medical instruments and devices for radiation therapy with a radio therapeutic substanceACTIVEDec 1, 2024
044Medical services, particularly services in the field of radiologic and nuclear-medical medicine, radiation oncology and for the treatment of skin cancer, none of the foregoing services involving stem cell therapyACTIVEDec 1, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 6, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 6, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 17, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 17, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 8, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 7, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 30, 2024IUAFUSE AMENDMENT FILED—
Dec 30, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 18, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2024EX5GSOU EXTENSION 5 GRANTED—
Jun 18, 2024EXT5SOU EXTENSION 5 FILED—
Jun 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 26, 2023EX4GSOU EXTENSION 4 GRANTED—
Dec 26, 2023EXT4SOU EXTENSION 4 FILED—
Dec 26, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 1, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 29, 2023EX3GSOU EXTENSION 3 GRANTED—
Jun 29, 2023EXT3SOU EXTENSION 3 FILED—
Jun 29, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 4, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 2, 2023EX2GSOU EXTENSION 2 GRANTED—
Jan 2, 2023EXT2SOU EXTENSION 2 FILED—
Jan 2, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 28, 2022EX1GSOU EXTENSION 1 GRANTED—
Jun 28, 2022EXT1SOU EXTENSION 1 FILED—
Jun 28, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 17, 2022DOCKASSIGNED TO EXAMINER—
Jan 4, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 17, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 17, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 17, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 9, 2021DOCKASSIGNED TO EXAMINER—
Aug 27, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 10, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance